Koninklijke Philips Nv (PHG) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Koninklijke Philips Nv (PHG) stock forecast summary
Our AI scores Koninklijke Philips Nv every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Koninklijke Philips Nv is a large-cap company with a market capitalization of $29.22B.
For PHG, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 35.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -24.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, PHG included.
PHG price chart and AI forecast
How PHG ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Koninklijke Philips Nv (PHG) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the X-Ray Apparatus & Tubes & Related Irradiation Apparatus peers listed below that report each metric. Statement values were filed in EUR and are shown converted to USD (flows at the trailing twelve-month average rate, balances at the balance-sheet date rate).
Valuation & Market
| Metric | PHG | Rank |
|---|---|---|
| Market Cap | $29.22B | – |
| EPS | $-2.44 | – |
| Revenue/Share | $84.55 | – |
Profitability & Margins
| Metric | PHG | Rank |
|---|---|---|
| ROE | -17.2% | – |
| ROA | -7.0% | – |
| ROIC | 1.6% | – |
| Gross Margin | 42.4% | – |
| Operating Margin | 0.4% | – |
| Net Margin | -2.6% | – |
| EBT Margin | -1.3% | – |
| Tax Rate | -111.2% | – |
The effective tax rate is outside the normal band, which points to a large non-recurring tax item in the trailing twelve months; headline net income, net margin and P/E are affected by it.
Financial Health
| Metric | PHG | Rank |
|---|---|---|
| Current Ratio | 1.32x | – |
| Quick Ratio | 0.94x | – |
| D/E Ratio | 1.46x | – |
| Financial Leverage | 2.46x | – |
| Working Capital | $2.85B | – |
Operational Efficiency
| Metric | PHG | Rank |
|---|---|---|
| Asset Turnover | 2.67x | – |
| Receivables Turnover | 20.4x | – |
| Inventory Turnover | 14.4x | – |
| Days Sales Outstanding | 18 days | – |
| Days Inventory | 25 days | – |
| Payables Period | 17 days | – |
| Cash Conversion Cycle | 26 days | – |
Income Statement
| Metric | PHG | Rank |
|---|---|---|
| Total Revenue | $81.41B | – |
| Operating Income | $350M | – |
| Net Income | -$2.13B | – |
| R&D Expense | $8.43B | – |
| Cost of Goods Sold | $46.88B | – |
Dividend & Shareholder Information
| Metric | PHG | Rank |
|---|---|---|
| Shares Outstanding | 963M | – |
| Net Income Growth | -127.8% | – |
| EPS Growth | -129.1% | – |
Balance Sheet Highlights (USD millions, converted from EUR)
| Total Current Assets | $11.67B | |
| Cash & Short-term Investments | $3.28B | |
| Accounts Receivable | $4.15B | |
| Inventory | $3.37B | |
| Total Liabilities | $18.74B | |
| Short-term Debt | $6.56B |
PHG quarterly financials and insider trading
Koninklijke Philips Nv (PHG) industry peers
Companies classified under the same SEC industry code as Koninklijke Philips Nv (X-Ray Apparatus & Tubes & Related Irradiation Apparatus): 3 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere PHG sits on the market map
Koninklijke Philips Nv (PHG) stock news
Loading...
Koninklijke Philips Nv (PHG) stock forecast FAQ
What is the Koninklijke Philips Nv (PHG) stock forecast?
Our AI scores Koninklijke Philips Nv every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Koninklijke Philips Nv stock predictions?
For PHG, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 35.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -24.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Koninklijke Philips Nv forecasts updated?
Koninklijke Philips Nv forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Koninklijke Philips Nv's industry peers?
3 issuers in our coverage, PHG included, share the SEC industry code X-Ray Apparatus & Tubes & Related Irradiation Apparatus. The largest are: Ge Healthcare Technologies Inc. (GEHC), Butterfly Network, Inc. (BFLY).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.